AI Verdict
MC has stronger fundamentals based on our AI analysis.
MC vs MBX Fundamental Comparison
| Metric | MC | MBX |
|---|---|---|
| Revenue | $1.5B | N/A |
| Net Income | $233.0M | $-87.0M |
| Net Margin | 15.4% | N/A |
| ROE | 41.0% | -23.6% |
| ROA | 13.4% | -22.6% |
| Current Ratio | N/A | 24.62x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.75 | $-2.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MC vs MBX: Frequently Asked Questions
Is MC or MBX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MC has stronger fundamentals. MC is rated BUY (78% confidence) while MBX is rated STRONG SELL (92% confidence). This is not investment advice.
How does MC compare to MBX fundamentally?
Moelis & Co has ROE of 41.0% vs MBX Biosciences, Inc.'s -23.6%. Net margins are 15.4% vs N/A respectively.
Which stock pays higher dividends, MC or MBX?
MC has a dividend yield of N/A or no dividend while MBX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MC or MBX for long term?
For long-term investing, consider that MC has BUY rating with 78% confidence, while MBX has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MC vs MBX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MC vs MBX, the AI consensus favors MC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.